D-0616-2023 Class II Terminated

Recalled by Astral SteriTech Private Ltd. — Vadodara, N/A

Recall Details

Product Type
Drugs
Report Date
May 24, 2023
Initiation Date
May 15, 2023
Termination Date
April 5, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
66,125 vials

Product Description

Ceftriaxone for Injection, USP 250 mg per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-094-02

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide within the United States

Code Information

All lots within expiry.